AltheaDx Nets $6M in Series A Financing | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics developer AltheaDx said today that it has reeled in $6 million in a Series A round of equity financing led by Telegraph Hill Partners of San Francisco.

AltheaDx will use the funds to support its partnerships with biopharmaceutical firms focused on developing companion diagnostics and biomarkers for use in making therapeutics safer, AltheaDx Co-founder and Co-CEO Magda Marquet said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.